A Phase 3 Open Label Study to Evaluate the Long-term Safety and Tolerability of ALKS 8700 in Adults with Relapsing Remitting Multiple Sclerosis
-
- STATUS
- Not Recruiting
Updated on 19 February 2024
Summary
The purpose of this research study is to test the long-term safety and treatment effect of ALKS 8700 in subjects who have relapsing-remitting MS.
Description
The purpose of this study is to test the long-term safety, tolerability and treatment effect of ALKS 8700 administered up to 96 weeks for subjects who have relapsing-remitting MS.
Details
| Condition | multiple sclerosis |
|---|---|
| Age | 18years - 65years |
| Clinical Study Identifier | TX5953 |
| Last Modified on | 19 February 2024 |
How understandable was the trial content above?
Hard to understand
Easy to understand
Similar trials to consider
Loading...
Not finding what you're looking for?
Sign up as a volunteer to stay informed
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteerStudy Definition
WikipediaAdd a private note
- Select a piece of text.
- Add notes visible only to you.
- Send it to people through a passcode protected link.